[Use of clobazam 20 mg in general practice].
Fifty practitioners treated 224 patients with clobazam for 4 weeks. The anxiolytic action, the tolerability, the degree of satisfaction and the dosage of clobazam were evaluated by means of a modified "Rating Scale for Anxiety" by Hamilton and self-evaluation scales. Clobazam proved to have an important anxiolytic activity together with good tolerability. The ability to concentrate was remarkably improved, which seems to confirm the specificity of the molecule (benzodiazepine-1,5). The reduction of anxiety and of anxious equivalents and the good tolerability of the product were confirmed by the judgement of satisfaction of the doctors as well as of their patients.
D000293:Adolescent; D000328:Adult; D000342:Affective Symptoms / Q000188:drug therapy*; D000368:Aged; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001569:Benzodiazepines; D001570:Benzodiazepinones / Q000627:therapeutic use*; D000078306:Clobazam; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011602:Psychophysiologic Disorders / Q000188:drug therapy*; D012893:Sleep Wake Disorders / Q000188:drug therapy
D014151:Anti-Anxiety Agents; D001570:Benzodiazepinones; D001569:Benzodiazepines; D000078306:Clobazam
Utilisation du clobazam 20 mg en pratique générale.